Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Forsteo

ApprovedSmall molecule

Forsteo is one of 12 small molecule programs targeting Ankle Fracture. It is currently in Approved.

1

Indications

6

Total Trials

0

Active Trials

11

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ankle FractureActive, not recruiting

Ankle FractureApproved

Active, not recruiting

Competition

Competitive Landscape

26 competitors in Ankle Fracture

#DrugCompanyPhaseTrials

Aleve

Alnylam Pharmaceuticals

Naropin

FFresenius Kabi Oncology Ltd.

MS Contin

HHikma Pharmaceuticals LLC

Adrenaline

SSamson Clinical Operations Pty Ltd

Oxycontin

Tylenol

Marcaine

Forsteo

Bayer Aspirin

Advil

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ankle Fracture1 trial

Ankle Fractures Treated With Teriparatide

Unknown status·NNottingham University Hospitals NHS Trust·Phase 4·NCT02955056·10 enrolled

Menopausal Women1 trial

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

Completed· Novartis logo

Novartis·Phase 1·NCT01224717·104 enrolled

Acute Lymphoblastic Leukemia1 trial

Nasally and sc Administered Teriparatide in Healthy Volunteers

Unknown status·NNottingham University Hospitals NHS Trust·Phase 1·NCT01913834·7 enrolled

Adult1 trial

Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults

Completed·SShenzhen Salubris Pharmaceuticals Co., Ltd.·Phase 1·NCT04747392·64 enrolled

Postmenopausal Women1 trial

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women

Completed·UUnigene Laboratories Inc.·Phase 2·NCT01321723·97 enrolled

1 more indication

Randomized Controlled Trial1 trial

Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial

Unknown status·SSeoul National University Bundang Hospital·Phase 4·NCT04241211·64 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Forsteo. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Forsteo compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Forsteo. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Novartis company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Novartis

Related News